Mon 1 July 2013, Financial Times

Private equity groups weigh Biomet exit

By Arash Massoudi and Anne-Sylvaine Chassany
Owners weigh a relisting of the US artificial hip and knee maker six years after taking the company private in an $11.4bn leveraged buyout

Similar articles

(what's this?)

ordered by similarity (order by date)